Persistence of mucosal CAR-T cells and inflammatory remodeling in enterocolitis associated with BCMA CAR-T cell therapy
- 23 September 2026
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- p. 1-13
Abstract
B cell-targeted therapies are expanding across oncologic and autoimmune indications, yet their consequences for mucosal immunity remain incompletely examined. Here we define the pathophysiology of ciltacabtagene autoleucel chimeric antigen receptor (CAR)-T cell-induced enterocolitis (EC) (CAR-TEC)—a severe complication of B cell maturation antigen-targeted CAR-T cell therapy in multiple myeloma. Using single-cell transcriptomics, flow cytometry and tissue imaging of intestinal biopsies from patients with CAR-TEC (n = 10), CAR-T cell-treated controls without EC (n = 7) and healthy volunteers (n = 26), we identify profound depletion of mucosal B cells and plasma cells accompanied by expansion of highly cytotoxic CAR-T cells and inflammatory myeloid, stromal and glial cell remodeling to be associated with CAR-TEC. Cell–cell communication analyses suggest a compensated mucosal state in CAR-T cell-treated controls, telocyte-driven stromal niche dysfunction as noted in CAR-TEC. Interferon- and Janus kinase (JAK) and signal transducer and activator of transcription-associated reprogramming was noted across stromal, endothelial and epithelial compartments, supporting JAK inhibition as a rational, mechanism-based therapeutic strategy. Upadacitinib—an oral selective JAK 1 inhibitor—resulted in clinical, endoscopic and histologic improvement in two people with CAR-TEC. Our findings define CAR-TEC as a multicompartment syndrome of severe mucosal dysregulation with implications for the emerging field of B cell-targeted therapies.Keywords
This publication has 46 references indexed in Scilit:
- Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label studyThe Lancet, 2021
- New insights into B cells as antigen presenting cellsCurrent Opinion in Immunology, 2021
- Single-Cell Analysis of Crohn’s Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF TherapyCell, 2019
- Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative ColitisCell, 2019
- Comprehensive Integration of Single-Cell DataCell, 2019
- Classical dendritic cells are required for dietary antigen–mediated induction of peripheral Treg cells and toleranceNature Immunology, 2016
- Angiopoietins in inflammation and their implication in the development of inflammatory bowel disease. A reviewJournal of Crohn's and Colitis, 2014
- A functional heteromeric MIF receptor formed by CD74 and CXCR4FEBS Letters, 2009
- “compositions”: A unified R package to analyze compositional dataComputers & Geosciences, 2008
- TGF-β Receptor Controls B Cell Responsiveness and Induction of IgA In VivoImmunity, 2000